This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Nov 16;360(9345):1603-4; author reply 1605.

doi: 10.1016/S0140-6736(02)11542-X.

Fondaparinux versus enoxaparin for prevention of venous thromboembolism

Javier Borja, Pere Olivella, Jorge Curto

PMID: 12443626
DOI: 10.1016/S0140-6736(02)11542-X

Comment

Fondaparinux versus enoxaparin for prevention of venous thromboembolism

Javier Borja et al. Lancet. 2002.

. 2002 Nov 16;360(9345):1603-4; author reply 1605.

doi: 10.1016/S0140-6736(02)11542-X.

Authors

Javier Borja, Pere Olivella, Jorge Curto

PMID: 12443626
DOI: 10.1016/S0140-6736(02)11542-X

No abstract available

PubMed Disclaimer

Comment on

Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
Lassen MR, Bauer KA, Eriksson BI, Turpie AG; European Pentasaccharide Elective Surgery Study (EPHESUS) Steering Committee. Lassen MR, et al. Lancet. 2002 May 18;359(9319):1715-20. doi: 10.1016/S0140-6736(02)08652-X. Lancet. 2002. PMID: 12049858 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information